1	CD30	CD30	_	_	_	_	_	_	_
2	ligation	ligation	_	_	_	_	_	_	_
3	induces	induce	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor-kappa	factor-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	lines	line	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	CD30	CD30	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	recently	recently	_	_	_	_	_	_	_
5	described	describe	_	_	_	_	_	_	_
6	member	member	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	tumor	tumor	_	_	_	_	_	_	_
10	necrosis	necrosis	_	_	_	_	_	_	_
11	factor/nerve	factor/nerve	_	_	_	_	_	_	_
12	growth	growth	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	superfamily	superfamily	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	show	show	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	following	follow	_	_	_	_	_	_	_
9	incubation	incubation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	L540	l540	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	Hodgkin	Hodgkin	_	_	_	_	_	_	_
15	â€™s	's	_	_	_	_	_	_	_
16	disease-derived	disease-derived	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cell-like	cell-like	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	CD30+	cd30+	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	agonistic	agonistic	_	_	_	_	_	_	_
27	anti-CD30	anti-cd30	_	_	_	_	_	_	_
28	monoclonal	monoclonal	_	_	_	_	_	_	_
29	antibodies	antibody	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	mAb	mab	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	M44	m44	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	M67	M67	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	two	two	_	_	_	_	_	_	_
38	nuclear	nuclear	_	_	_	_	_	_	_
39	factor	factor	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
42	B	B	_	_	_	_	_	_	_
43	DNA	DNA	_	_	_	_	_	_	_
44	binding	binding	_	_	_	_	_	_	_
45	activities	activity	_	_	_	_	_	_	_
46	were	be	_	_	_	_	_	_	_
47	induced	induce	_	_	_	_	_	_	_
48	in	in	_	_	_	_	_	_	_
49	nuclear	nuclear	_	_	_	_	_	_	_
50	extracts	extract	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	as	as	_	_	_	_	_	_	_
53	determined	determine	_	_	_	_	_	_	_
54	in	in	_	_	_	_	_	_	_
55	gel	gel	_	_	_	_	_	_	_
56	retardation	retardation	_	_	_	_	_	_	_
57	assays	assay	_	_	_	_	_	_	_
58	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	mAb	mab	_	_	_	_	_	_	_
6	towards	towards	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	rapid	rapid	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	it	it	_	_	_	_	_	_	_
15	occurred	occur	_	_	_	_	_	_	_
16	within	within	_	_	_	_	_	_	_
17	20	20	_	_	_	_	_	_	_
18	min	min	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	sustained	sustained	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	up	up	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	6	6	_	_	_	_	_	_	_
27	h	h	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	comparison	comparison	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	isotype-matched	isotype-matched	_	_	_	_	_	_	_
6	antibody	antibody	_	_	_	_	_	_	_
7	had	have	_	_	_	_	_	_	_
8	no	no	_	_	_	_	_	_	_
9	effect	effect	_	_	_	_	_	_	_
10	on	on	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	helper	helper	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	Th	Th	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	clones	clone	_	_	_	_	_	_	_
11	functionally	functionally	_	_	_	_	_	_	_
12	characterized	characterize	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	being	be	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	type	type	_	_	_	_	_	_	_
18	0	0	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	type	type	_	_	_	_	_	_	_
21	1	1	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	type	type	_	_	_	_	_	_	_
24	2	2	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	28	28	_	_	_	_	_	_	_
27	%	%	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	<	<	_	_	_	_	_	_	_
30	1	1	_	_	_	_	_	_	_
31	%	%	_	_	_	_	_	_	_
32	und	und	_	_	_	_	_	_	_
33	93	93	_	_	_	_	_	_	_
34	%	%	_	_	_	_	_	_	_
35	CD30+	cd30+	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	respectively	respectively	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	extent	extent	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	CD30-mediated	cd30-mediated	_	_	_	_	_	_	_
44	NF-kappa	NF-kappa	_	_	_	_	_	_	_
45	B	B	_	_	_	_	_	_	_
46	activation	activation	_	_	_	_	_	_	_
47	correlated	correlate	_	_	_	_	_	_	_
48	with	with	_	_	_	_	_	_	_
49	the	the	_	_	_	_	_	_	_
50	proportion	proportion	_	_	_	_	_	_	_
51	of	of	_	_	_	_	_	_	_
52	CD30+	cd30+	_	_	_	_	_	_	_
53	cells	cell	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	all	all	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	lines	line	_	_	_	_	_	_	_
5	investigated	investigate	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	complexes	complex	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	following	follow	_	_	_	_	_	_	_
13	CD30	cd30	_	_	_	_	_	_	_
14	engagement	engagement	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	shown	show	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	contain	contain	_	_	_	_	_	_	_
19	p50	p50	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B1	B1	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	p65	p65	_	_	_	_	_	_	_
24	RelA	RelA	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	possibly	possibly	_	_	_	_	_	_	_
28	other	other	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	factors	factor	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Collectively	collectively	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	our	our	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	nuclear	nuclear	_	_	_	_	_	_	_
8	translocation	translocation	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	rank	rank	_	_	_	_	_	_	_
15	among	among	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	short-term	short-term	_	_	_	_	_	_	_
18	cellular	cellular	_	_	_	_	_	_	_
19	responses	response	_	_	_	_	_	_	_
20	elicited	elicit	_	_	_	_	_	_	_
21	following	follow	_	_	_	_	_	_	_
22	CD30	cd30	_	_	_	_	_	_	_
23	ligation	ligation	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

